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Ethnopharmacological relevance The aerial components of Meconopsis simplicifolia (D. Don) Walpers are 
indicated in Bhutanese traditional medicine for treating malaria, coughs and colds, and the infections of 
the liver, lung and blood. This study is to validate the ethnopharmacological uses of this plant and also 
identify potent antimalarial drug leads through bioassays of its crude extracts and phytochemical 
constituents. 
Materials and methods Meconopsis simplicifolia (D. Don) Walpers was collected from Bhutan and its 
crude MeOH extract was subjected to acid-base fractionation. Through repeated extractions, separations 
and spectroscopic analysis, the alkaloids obtained were identified and tested for their antimalarial and 
cytotoxicity activities. 
Results Phytochemical studies resulted in the isolation of one new protoberberine type alkaloid which we 
named as simplicifolianine and five known alkaloids: protopine, norsanguinarine, dihydrosanguinarine, 
6-methoxydihydrosanguinarine and oxysanguinarine. Among the five of the alkaloids tested, 
simplicifolianine showed the most potent antiplasmodial activities against the Plasmodium falciparum 
strains, TM4/8.2 (chloroquine–antifolate sensitive strain) and K1CB1 (multidrug resistant strain) with 
IC50 values of 0.78 μg/mL and 1.29 μg/mL, respectively. The compounds tested did not show any 
significant cytotoxicity activities against human oral carcinoma KB cells and normal Vero cells of African 
kidney epithelial cells. 
Conclusions This study validated the traditional uses of the plant for the treatment of malaria and 
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ABSTRACT 
Ethnopharmacological relevance: The aerial components of M. simplicifolia are indicated in 
Bhutanese traditional medicine for treating malaria, coughs and colds, and the infections of 
the liver, lung and blood.  
Aim of the study: To validate the ethnopharmacological uses of this plant and also identify 
potent antimalarial drug leads through bioassays of its crude extracts and phytochemical 
constituents. 
Materials and methods: M. simplicifolia was collected from Bhutan and its crude MeOH 
extract was subjected to acid-base fractionation. Through repeated extractions, seperations 
and spectroscopic analysis, the alkaloids obtained were identified and tested for their 
antimalarial and cytotoxicity activities.   
Results: Phytochemical studies resulted in the isolation of one new protoberberine type 
alkaloid which we named as simplicifolianine and five known alkaloids: protopine, 
norsanguinarine, dihydrosanguinarine, 6-methoxydihydrosanguinarine and oxysanguinarine. 
Among the five of the alkaloids tested, simplicifolianine showed the most potent 
antiplasmodial activities against the Plasmodium falciparum strains, TM4/8.2 (chloroquine-
antifolate sensitive strain) and K1CB1 (multidrug resistant strain) with IC50 values of 0.78 
µg/ml and 1.29 µg/ml, respectively. The compounds tested did not show any significant 
cytotoxicity activities against human oral carcinoma KB cells and normal Vero cells of 
African kidney epithelial cells.  
Conclusions: This study validated the traditional uses of the plant for the treatment of malaria 
and identified a new alkaloid, simplicifolianine as a potential antimalarial drug lead.   
Keywords: Meconopsis simplicifolia, simplicifolianine, antimalarial, anticancer, medicinal 
plant, Bhutanese traditional medicine. 
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1. Introduction 
Meconopsis (Papaveraceae) comprises about 43-49 species with the majority of these 
restricted to the Himalaya and only one species, M. cambrica, being endemic to Europe 
(Debnath and Nayar, 1986; Zhou et al., 2009). The plants of this genus are prized for their 
ornamental and medicinal qualities. Many Meconopsis species, such as M. integrifolia, M. 
torquata, M. horridula, M. racemosa and M. quintuplinervia have long been used in Tibetan 
folk remedies for treating various disorders (Luo et al., 1984; Zhou et al., 2009; Yue et al., 
2010). Out of 13 Meconopsis species reported from Bhutan (Grierson and Long, 1984), seven 
of them (M. horridula, M. paniculata, M. napaulensis, M. superba, M. primulina, M. 
discigera and M. simplicifolia) were said to have medicinal properties. However, only two 
species (M. horridula and M. simplicifolia) are currently used in Bhutanese traditional 
medicine (BTM) for various formulations (Tenzin, 2007; Wangchuk et al., 2008).  
M. simplicifolia is locally known as ud-pel-sngon-po and grows to 30-70 cm tall with 
narrowly oblongated seed capsules, blue flowers, and hairy stems and leaves (Anonymous, 
2008). Its aerial parts (stems, leaves, flowers and fruit), in combination with other ingredients, 
are used for preparing more than eight important BTM multi-ingredient formulations. As an 
individual plant, it is indicated for treating coughs and colds, fever and infections in the liver, 
lung and blood which show correlations to the symptoms of cancer, microbial infections and 
malaria (Wangchuk et al., 2008, 2011). Malaria causes 2-3 million deaths each year (Marti et 
al., 2010). In Bhutan, there were 436 microscopy-confirmed indigenous cases with 140 (32%) 
cases being due to Plasmodium falciparum (Yangzom et al., 2010). As the artemisinin-based 
combination therapies (ACTs), including artesunate monotherapy, have shown signs of lower 
efficacy (Dondorp et al., 2009) against the resistant Plasmodium falciparum strains, the battle 
against malaria is seriously impaired. Therefore, the need for new antimalarial agents has 
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become imperative. History tells us that the plant-based drugs including traditional medicinal 
plants and compounds derived from them are the important sources of antimalarial drugs. The 
BTM, which depends upon the country’s rich biodiversity, may offer alternative treatment 
regimens by promising a source of antimalarial extracts and new drug lead compounds as 
revealed by previous studies on Bhutanese medicinal plants (Wangchuk et al., 2008, 2010, 
2011, 2012a, 2012b). Our recent biological activity studies of different solvent extracts of M. 
simplicifolia showed remarkable antiplasmodial activity against a multidrug resistant strain 
(K1CB1) and a chloroquine and antifolate sensitive wild type strain (TM4/8.2) of 
Plasmodium falciparum with IC50 values of 6.39 µg/ml and 0.40 µg/ml, respectively 
(Wangchuk et al., 2011). Based on this earlier finding we have further investigated this plant 
for its phytochemicals and their biological activities and consequently discovered a new 
protoberberine type alkaloid along with five known protopine and benzophenanthridine type 
alkaloids (1-6) (Fig. 1) with potent antimalarial activities and cytotoxicities. The findings are 
described in this paper. 
 
2. Materials and methods  
2.1. Plant material  
The aerial components of wild type M. simplicifolia were collected from near the 
Lingzhi Makhang (Altitude: 4183 m; Latitude: 27° 50' 29.9''; Longitude: 89° 25' 41.5''; global 
positioning system (GPS) point number: 138; Site number: P138; Slope: 25°; Aspect: North-
East), under Lingshi region of Bhutan in July 2009. The herbarium voucher specimen number 
2 was authenticated by Mr. Samten and deposited at the herbarium of the Manjong Sorig 
Pharmaceuticals, Thimphu, Bhutan. The plant has a low average population density of 0.6 
plants/m2 and usually inhabits damp ground, rocky alpine hillsides, and screes at the margins 
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of shrubby mountain vegetation (Anonymous, 2008) growing in association with Rubus and 
Rhodiola species, Rhododendron anthopogon and Bistorta macrophylla. It is distributed in 
Lingzhi, Bumthang and Gasa districts of Bhutan.  
 
2.2. Phytochemical investigation and sample preparation methods 
2.2.1 General instrumentations 
The crude methanol extract, fractions and pure isolates of M. simplicifolia were stored 
at 5 °C until required for further purification or testing. The extracts and fractions were 
concentrated using a rotary evaporator under reduced pressure at 35-50 °C. Separation and 
purification of alkaloids were achieved using flash column chromatography (CC) packed with 
Merck Kieselgel 60 PF254 and an aluminium-backing silica plates (0.2 mm silica thickness, 
Merck). Separated bands or spots on TLC plates were visualized under UV light (short 
wavelength of 254 nm, long wavelength of 366 nm) and by staining with Dragendorff’s 
reagent which was prepared using the methods described by Svendsen and Verpoorte (1983). 
LR-ESI-MS, LR-EI-MS and the HR-ESI-MS were obtained using a Micromass Waters 
Platform LCZ (single quadrupole, MeOH as solvent), Shimadzu GCMS-QP-5050 (direct 
insertion technique at 70 eV) and the Micromass Waters Q-ToF Ultima (quadrupole time-of-
flight) mass spectrometer, respectively. The 1H-NMR, gCOSY, 13C-NMR, APT, gHMBC, 
gHSQC, and gNOESY spectral data of the relevant compounds (dissolved in deuterated 
solvents CD3OD or CDCl3) were generated using either a 500 MHz Varian Unity Inova or 
500 MHz Varian Premium Shield (VNMRS PS 54) or 300 MHz Varian Mercury NMR 
spectrometer. A hot-stage apparatus was used for determining the melting points.  
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2.2.2.  Separation/isolation of alkaloids 
The air-dried plant material (2 kg) was chopped into small pieces and was repeatedly 
extracted with analytical grade or HPLC grade methanol (5 x 3 L over 48 h). The extract was 
filtered and then concentrated using a rotary evaporator to afford the crude methanol extract 
(43.1 g). This extract was acidified with 5% HCl and then extracted with CH2Cl2 (5 x 60 mL) 
which upon evaporation of the solvent yielded the CH2Cl2 extract (9.8 g). The remaining 
acidified aqueous solution was basified (pH 9-12) with NH4OH solution and then extracted 
with CHCl3 (5 × 60 mL) to obtain the crude alkaloid CHCl3 extract (446 mg). Repeated 
fractional crystallizations and separations by CC on silica gel (mobile phase: gradient eluant 
of increasing solvent polarities mainly using MeOH and CHCl3) and preparative thin layer 
chromatography (PTLC) yielded six alkaloids (1–6) (Fig. 1).  
 
Fig. 1. The structures of the six isolated compounds from M. simplicifolia. 
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The CHCl3 extract upon initial flash CC over silica gel (120 g, 200-300 mesh), eluting 
with a gradient solvent system of MeOH-CHCl3 (in a v/v% ratio of 0:100, 2:98, 4:96, 6:94, 
8:92, 10:90, 20:80, 30:70, 50:50), yielded fractions CHCl3-F1 to CHCl3-F8. Fraction CHCl3-
F1 upon final separation using PTLC and CHCl3 as the mobile phase, yielded compound 3 (3 
mg). Fractions CHCl3-F5 and CHCl3-F6 were combined and separated using CC (gradient 
eluant, MeOH-CHCl3) followed by PTLC (mobile phase, MeOH-CHCl3 (4:96, 100 mL)) 
which yielded compound 2 (69.8 mg, major alkaloid of a plant). Fractions CHCl3-F7 and 
CHCl3-F8 were combined and separated by CC with a gradient solvent system of MeOH-
CHCl3 (200 mL, v/v% ratio of 20:80, 30:70) to obtain sub-fractions CHCl3-F78.1 to CHCl3-
F78.5. Final separation of sub-fraction CHCl3-78.4 using PTLC and the mobile phase system 
of MeOH-CHCl3 (v/v ratio of 15:85) yielded a new compound 1 (3 mg). The CH2Cl2 extract 
upon initial flash CC on silica gel eluting with a gradient solvent system of MeOH-CH2Cl2 (in 
a v/v% ratio of 0:100, 0.5:99.5, 1.5:98.5, 2.5:97.5, 3.5:96.5, 5:95, 10:90, 20:80, 50:50) yielded 
fractions CH2Cl2-F1 to CH2Cl2-F18. Fraction CH2Cl2-F4 upon crystallization from CHCl3-
MeOH (1:1) gave crystals of compound 4 (11.6 mg). Its mother liquor was purified by CC 
eluting with CHCl3 (100%) to obtain five sub-fractions CH2Cl2-F4.1 to CH2Cl2-F4.5. The 
sub-fractions CH2Cl2-F4.4 and CH2Cl2-F4.5 were combined and repeatedly separated. Final 
separation of fraction CH2Cl2-F4.45.3.1 by PTLC (CHCl3-ethyl acetate-MeOH in v/v ratio of 
90:8:2), yielded compound 6 (0.9 mg). Fraction CH2Cl2-F10 upon separation using CC with a 
gradient solvent system of MeOH-CH2Cl2 (in a v/v ratio of 0:100, 0.5:99.5, 1:99, 2:98, 5:95, 
10:90, 100:0) gave sub-fractions CH2Cl2-F10.1 to CH2Cl2-F10.4. Crystallization of the sub-
fraction CH2Cl2-F10.1 from CHCl3-MeOH (97:3) furnished compound 5 (3.3 mg).  
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2.2.3.  Structure elucidation and identification of alkaloids 
Compound 1 was determined as a new protoberberine type alkaloid, which we named as 
simplicifolianine (1) after the species name of this plant. It was isolated as a faintly brown 
amorphous solid which melted at 170.8-171.3 oC. The LR-ESI-MS spectrum indicated the 
[M]+ ion peak at m/z 380. LR-EI-MS (m/z): 380 [M]+, 364, 350, 336, 308, 280, 228, 207, 191, 
167, 149, 129, 111. Its even molecular ion suggested either zero or an even number of 
nitrogen or an iminium species. The HR-ESI-MS spectrum supported the molecular formulae 
of C21H18NO6 with an actual m/z 380.1130 [M]
+ and a calculated mass of 380.1134.  
The structure of this new compound (1) has been established using 1D and 2D-NMR 
spectral data. Its 1H and 13C-NMR spectra, and gCOSY correlation are presented in Table 1. 
The long range gHMBC correlation established the C→H and H→C cross-correlations 
among the H and C-atoms (Fig. 2a) and the NOESY correlations (Fig. 2b) further confirmed 
the structure 1. This compound is structurally related to alborine (Hai-feng et al., 2011). 
 
 
                                          (a)     (b) 
         Fig. 2. Key spectral correlations of 1; (a) gHMBC and (b) NOESY. 
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Table 1 
1H NMR (500 MHz, methanol-d4,), 
13C NMR (125 MHz, methanol-d4), gCOSY spectroscopic 
data of simplicifolianine (1). 
Carbon position δ C in ppm 
     δ H in ppm 
      (multiplicity,  J in Hz) 
gCOSY 
(1H→1H) 
1 143.7     
2 138.3   
3 152.5   
4 104.3 6.71 (1H, s) 3.15 
4a 134.2   
5 29.3 3.15 (2H, t, 5.75) 4.70 
6 56.4 4.70 (2H, t, 5.75) 3.15 
8 146.2 9.31 (1H, s) 7.48 
8a 115.6   
9 104.3 7.48 (1H, s) 9.31 
10 155.6   
11 139.6   
12 138.4   
12a 125.8   
13 121.9 9.26 (1H, s)  
13a 153.4   
13b 114.2   
OMe 60.9 4.17 (3H, s)  
2,3-OCH2O 103.7 6.09 (2H, s)  
10,11-OCH2O 105.3 6.34 (2H, s)  
C (12)-CH2OH 55.2 5.02 (2H, s)   
 
The other five known alkaloids were identified as protopine (2), norsanguinarine (3), 
dihydrosanguinarine (4), 6-methoxydihydrosanguinarine (5) and oxysanguinarine (6) (Fig.1) 
through MS library matching techniques, and MS and NMR spectral data comparisons with 
the pertinent literature. The MS ion fragmentation pattern of compound 2 with a mass of m/z 
353 [M+•] matched that of protopine reported in the MS library (NIST08s, Entry # 26245, 
CAS: 130-86-9, RetIndex: 2943) and further its 1H and 13C-NMR spectroscopic data agreed 
with those reported (Takahashi et al., 1985; Seger et al., 2004; Wangchuk et al., 2010). It was 
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the major component of the plant. Compounds 3-6 are benzophenanthridine type alkaloids. 
While compound 3 was reported from the genus Meconopsis (M. quintuplinervia) (Shang et 
al., 2003), compounds 4-6 were isolated from this genus for the first time. The MS, 1H and 
13C-NMR spectroscopic data of compounds 3 (Tousek et. al., 2004), 4 (Williams and Ellis, 
1993; Choi et al., 2010; Miao et. al, 2011; Yao et al., 2011), 5 (Zhang et al., 1995; Dostal et 
al., 1998; Choi et al., 2010; Miao et al., 2011) and 6 (Williams and Ellis, 1993; Miao et al., 
2011) agreed with those from their respective literature. Crystals of compound 4 and 5 were 
grown using chloroform/methanol and their single crystal X-ray crystallographic structures 
are presented here for the first time (Fig. 3a-b).  
 
Fig.3. Single crystal X-ray structures of (a) dihydrosanguinarine (4), and (b) 6-methoxy-
dihydrosanguinarine (5). 
 
X-ray diffraction images were measured on a Nonius KappaCCD diffractometer (Mo 
Kα radiation, graphite monochromator, λ=0.71073 Å) and data extracted using the DENZO 
package (Otwinowski and Minor, 1997). Structure solution was by direct methods 
(SUPERFLIP, SIR92) (Altomare et al, 1994; Palatinus and Chapuis, 2007). The structures 
were refined using the CRYSTALS program package (Betteridge et al., 2003). Atomic 
coordinates, bond lengths and angles and displacement parameters have been deposited at the 
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Cambridge Crystallographic Data Centre (CCDC no. 929725, 929726).  These data can be 
obtained free-of-charge via www.ccdc.cam.ac.uk/data_requerst/cif, by emailing 
data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic Data 
Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033. Crystal data for 
compound 4: C20H15NO4, Mr 333.34, T = 200K, triclinic, Pī, a = 9.3269 (2) Å, b = 10.2708 
(2) Å, c = 17.5397 (3) Å, α = 103.6455 (9)°, β = 100.3950 (12)°, γ = 103.6436 (12)°, V = 
1536.33 (5) Å3, Z = 4, F(000) = 696, Dx = 1.441 g cm
–3, µ = 0.10 mm–1, specimen = 0.47 × 
0.34 × 0.26 mm (colorless block). 40000 reflections were measured to 2θmax = 60° and 
merged to 8969 unique data.  Final R = 0.066 [for 7763 reflections with F2 > 2σ(F2)], wR = 
0.194 (all data), S = 1.02. Crystal data for compound 5: C21H17NO5, Mr 363.37, T = 200K, 
monoclinic, P21/n, a = 12.3894 (3) Å, b = 7.7519 (1) Å, c = 18.2571 (4) Å, β = 103.7510 
(11)°, V = 1703.18 (6) Å3, Z = 4, F(000) = 760, Dx = 1.417 g cm
–3, µ = 0.10 mm–1, specimen 
= 0.59 × 0.22 × 0.10 mm (pale brown plate). 35751 reflections were measured to 2θmax = 55° 
and merged to 3876 unique data.  Final R = 0.040 [for 2968 reflections with F2 > 2σ(F2)], wR 
= 0.103 (all data), S = 0.98.  
The isolated and identified compounds 1-5 were studied for their pharmacological 
activities. 
   
2.3. Bioassay methodology  
2.3.1. Antiplasmodial assay 
 Compounds 1-5 were tested in vitro against a multidrug resistant K1CB1 strain and a 
wild type chloroquine and antifolate sensitive TM4/8.2 strain of Plasmodium falciparum. The 
method described by Trager and Jensen (1976) was used for maintaining the parasites in 
human red blood cells in RPMI 1640 medium supplemented with 25 mM of HEPES, 0.2% of 
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sodium bicarbonate, and 8% human serum in a 3% carbon dioxide gas incubator maintained 
at 37 oC.  The test samples were made up in DMSO solution and the in vitro antiplasmodial 
activity testing was carried out using the Microdilution Radioisotope Technique (as detailed 
in Wangchuk et al., 2011). The test sample (25 µL, in the culture medium) was placed in 
triplicate in a 96-well plate where parasitised erythrocytes (200 µL) with a cell suspension 
(1.5%) of parasitemia (0.5-1%) were then added to the wells. Generally, the ranges of the 
final concentrations of the samples varied from 2 x 10-5 to 1 x 10-7 M or up to 1 x 10-4 g/mL 
with 0.1% of the organic solvent. Due to the poor solubility of some samples, only about 10-5 
g/mL final concentration could be tested. The plates were then cultured under standard 
conditions for 24 h after which 3H-hypoxanthine (25 µL, 0.5 µCi) was added to the culture 
medium. The culture was incubated (18-20 h) after which the DNA from the parasite was 
harvested from the culture onto glass fibre filters and a liquid scintillation counter was used to 
determine the amount of 3H-hypoxanthine incorporation (Desjardins et al., 1979; 
Kamchonwongpaisan et al., 2004). The inhibitory concentration of the sample was 
determined from its dose-response curves or by calculation. The assay was performed in at 
least three replicates. Chloroquine (Sigma company), pyrimethamine (Sigma company) and 
cycloguanil were used as positive controls for both plasmodial strains (Table 2). DMSO 
(0.1%) and distilled water were used as controls to rule out the solvent effects on the bioassay 
results of the test samples. All the experiments were performed three times in duplicate (3x2).   
 
2.3.2. Cytotoxicity assay 
Normal Vero cells from kidney of African green monkey, Cecopithecus aethiops and 
human oral carcinoma KB cells were maintained and cultured in MEM/EBSS supplemented 
with heated-inactivated fetal bovine serum (10%), NaHCO3 (2.2 g/L) and  of sodium pyruvate 
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(1%). KB cell lines were cultured in DMEM/low glucose supplemented with heated-
inactivated fetal bovine serum (10%), NaHCO3 (3.7 g/L) and non-essential amino acids (1%). 
Cytotoxicity was evaluated by the sulforhodamine B (SRB) assay (OD510 nm) as reported 
(Wangchuk et al., 2012a). Doxorubicin and ellipticine were used as positive control drugs for 
cytotoxicity activities (Table 2).  
 
3. Results and Discussions 
Since the crude extracts of a Bhutanese antimalarial medicinal plant, M. simplicifolia 
has exhibited significant antiplasmodial activity (Wangchuk et al., 2011), we examined 
compounds 1 and 3-5 for their antiplasmodial and cytotoxic activities (Table 2). Because of 
solubility problems, the IC50 values could not be accurately determined for compounds 3-5 
and compound 6 was not tested due to its limited quantity.  
The new protoberberine alkaloid, simplicifolianine (1) showed the most potent 
antiplasmodial activity against the P. falciparum strains, a wild type chloroquine and 
antifolate sensitive strain-TM4/8.2 and a multidrug resistant strain-K1CB1 with IC50 values of 
0.78 µg/mL and 1.29 µg/mL, respectively. This potent antiplasmodial activity was of similar 
range to that of the parent crude chloroform alkaloid extract against TM4/8.2 but nearly six 
times more potent than the crude extracts against K1CB1. Therefore, we have identified 
simplicifolianine (1) as a potential new drug lead on which a patent can be filed.  
The fact that the low cytotoxicity of compound (1) and the crude extract against human 
oral carcinoma KB cells and normal Vero epithelial cells makes the activity more interesting 
and demonstrated the plant’s potential safety for use in BTM.  
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Table 2 
Antiplasmodial activity (IC50 in µg/mL) of the alkaloids 1 and 3-5 isolated from M. 
simplicifolia. Also reproduced in the table are the data previously reported on the crude 
extracts and protopine.  
 
a original activity taken from Wangchuk et al. (2011). 
b original activity taken from Wangchuk et al. (2012).  
c reference drugs for antiplasmodial activity. 
d reference drugs for cytotoxicity activity. 
 
Protopine (2) has been isolated from different plant species and in our earlier studies, 
we established its antiplasmodial activity against the same strains as highly significant 
(Wangchuk et al., 2010; 2012b) (Table 2) and has been also reported to have broad range of 
Antiplasmodial Cytotoxicity 
Samples  
TM4/8.2 K1CB1     Vero cells KB cells
MeOH extract <12.5a 12.5a > 10 a > 10 a
CH2Cl2 extract 15.50  ± 1.95
 a 12.80  ± 2.63 a > 25 a > 25 a
CHCl3 alkaloid extract 0.40  ± 0.00
 a 6.39 ± 2.73 a > 25 a > 25 a
Simplicifolianine (1) 0.78  ± 0.14 1.29 ± 0.54 > 3.79 > 3.79
Protopine (2) 1.45 ± 0.53b   1.38 ± 0.31b > 3.50b > 3.50b
Norsanguinarine (3) > 0.32       > 0.32 > 0.32 > 0.32
Dihydrosanguinarine (4) > 3.33 > 3.33 > 3.33 > 3.33
6-Methoxydihydrosanguinarine (5) > 3.63 > 3.63 > 3.63 > 3.63
Chloroquinec    0.010 0.089 
Cycloguanilc 0.009 0.810
Pyrimethaminec  0.020 7.700
Ellipticined   0.093
Doxorubicind   0.56
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biological activities (Vacek et al., 2010). Due to limitation in solubility of compounds 3-5, the 
highest concentration tested were 0.32, 3.33 and 3.63 µg/mL, respectively. At such 
concentrations, compound 3 and 4 did not show any significant antiplasmodial activities nor 
the cytoxicities. However, compound 5 exhibited about 10-20% inhibitory effect against both 
parasite strains with no cytotoxicity against the mammalian cells.  
Since compounds 1 and 2 exhibited highly significant antimalarial activities and that 
protopine (2) was the major alkaloid present, it can be deduced that these alkaloids, either 
alone or in combination, may be responsible for the major antiplasmodial activities of the 
extract of this plant. Considering the increased resistance of the parasites to the conventional 
antimalarial drugs (Dondorp et al., 2009; Marti et al., 2010), these findings are timely as they 
provide a new potential drug lead targeting malarial infections. The Bhutanese traditional 
formulae involving this plant have potential to become an alternative treatment regimen for 
malaria and could potentially lead to the development of new hybrid of antimalarial drugs 
based on the lead compound identified here. Reports on compound 5 indicated 
antiproliferative effects on K549 human lung cancer cells, PC3 human prostrate cancer cells, 
MCF-7 human breast cancer cells and A562 human leukemia cells (Cho, 2001) and showed 
an inhibitory effect on the growth of human colon carcinoma cells and induced apoptosis (Lee 
et al., 2004). However, this compound exhibited no cytotoxicity against KB and Vero cells in 
our study at the highest concentration tested. This compound was also reported to display 
anti-platelet aggregation activity (Chen et al., 2001).  
 From our earlier studies of the crude extracts of this plant, we concluded that this plant 
had only weak antibacterial properties against Staphylococcus aureus, methicillin resistant S. 
aureus (MRSA), Bacillus subtilis and Helicobacter pylori (Wangchuk et al., 2011). Based on 
these results, the pure isolates from this plant were not tested for their antimicrobial activities. 
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However, Navaroo and Delgado (1999) and Feng et al. (2011), reported that 
dihydrosanguinarine (4) displayed varying antimicrobial activities against S. aureus, 
Streptococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, 
Candida albicans, Botrytis cinerea, Phytophthora capsici and Alternaria solani. Compound 5 
(6-methoxydihydrosanguinarine or 6-methoxysanguinarine or often reported as 8-
methoxydihydrosanguinarine) was also reported to have moderate to weak antimicrobial 
activity against MRSA (Choi et al., 2010), S. aureus, E. coli and A. hydrophila with MIC 
values ranging from 12.5-50 µg/mL (Miao et al., 2011). Compound 3 exhibited antifungal 
activity against phytopathogenic fungi A. brassiciola and C. maculans with 75-80% inhibition 
at 200 µg/mL (Singh et al., 2009) and compound 4 showed significant antiparasitic effect 
against Ichthyophthirius multifiliis in richadsin with an IC50 value of 5.2 µg/mL (Yao et al., 
2011).  
 
4. Conclusion and future directions 
In summary, this phytochemical study of M. simplicifolia found the following: 1) a new 
protoberberine type alkaloid which we named as simplicifolianine (1); 2) protopine (2) was 
identified as the major alkaloid constituent; 3) compound 1 showed significant in vitro 
antiplasmodial activity with low cytotoxicity and therefore, we have identified it as a potential 
antimalarial drug lead; and 4) the in vitro bioassay results of the crude extracts and the pure 
compounds 1 and 2 were proportionate with the ethnopharmacological uses of this plant and 
thus substantiated its usage in a crude drug form in BTM, individually or in combination with 
other medicinal ingredients, to treat malaria.  
In future, scale-up isolation of the minor alkaloids, non-alkaloids and the essential oil 
components and the evaluation of their antiplasmodial and anticancer activities will be 
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undertaken. As resistance to the front line antimalarial drugs appears to be increasing, further 
work including the in vivo studies on compounds 1 and 2 which showed strong antiplasmodial 
activities is essential. Assessing the antimalarial and anticancer activities of formulations 
comprising mixtures of various ratios of the two most active compounds could also 
potentially give interesting results and could shed light on their synergism.  
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